irinotecan has been researched along with glucose, (beta-d)-isomer in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (60.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kanzawa, F; Kubota, N; Nishio, K; Saijo, N | 1 |
| Arioka, H; Bojanowski, K; Fukuda, M; Ishida, T; Kanzawa, F; Nishio, K; Ogasawara, H; Oka, M; Saijo, N | 1 |
| Saijo, N | 1 |
| Bachand, C; Balasubramanian, BN; Beaulieu, F; Eummer, JT; Fairchild, CR; Frennesson, DB; Kramer, R; Langley, DR; Lee, FY; Long, BH; Mahler, M; Martel, A; Naidu, BN; Rose, WC; Ruediger, E; Saulnier, MG; Solomon, C; St Laurent, DR; Stadnick, LK; Stoffan, KM; Vyas, DM; Wong, H; Wright, JJ; Zimmermann, K | 1 |
| Baechler, S; Barth, SW; Briviba, K; Esselen, M; Marko, D; Skrbek, S; Watzl, B; Winkler, S | 1 |
1 review(s) available for irinotecan and glucose, (beta-d)-isomer
| Article | Year |
|---|---|
New chemotherapeutic agents for the treatment of non-small cell lung cancer: the Japanese experience.
Topics: Alkaloids; Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carbazoles; Carcinoma, Non-Small-Cell Lung; Clinical Trials as Topic; Docetaxel; Glucosides; Humans; Irinotecan; Japan; Lung Neoplasms; Mitomycin; Mitomycins; Neoplasms, Experimental; Paclitaxel; Purine Nucleosides; Staurosporine; Taxoids; Treatment Outcome; Vinblastine; Vinorelbine | 1998 |
4 other study(ies) available for irinotecan and glucose, (beta-d)-isomer
| Article | Year |
|---|---|
Antitumor activities of a new indolocarbazole substance, NB-506, and establishment of NB-506-resistant cell lines, SBC-3/NB.
Topics: Antineoplastic Agents; Camptothecin; Carbazoles; Carcinoma, Small Cell; Cell Nucleus; Drug Resistance; Glucosides; Humans; In Vitro Techniques; Irinotecan; Topoisomerase I Inhibitors; Tumor Cells, Cultured | 1995 |
Synergism between cisplatin and topoisomerase I inhibitors, NB-506 and SN-38, in human small cell lung cancer cells.
Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Camptothecin; Carbazoles; Carcinoma, Small Cell; Cell Division; Cell Nucleus; Cell Survival; Cisplatin; DNA Repair; Dose-Response Relationship, Drug; Drug Synergism; Enzyme Inhibitors; Glucosides; Humans; Irinotecan; Lung Neoplasms; Topoisomerase I Inhibitors; Tumor Cells, Cultured | 1996 |
Discovery of a fluoroindolo[2,3-a]carbazole clinical candidate with broad spectrum antitumor activity in preclinical tumor models superior to the marketed oncology drug, CPT-11.
Topics: Animals; Antineoplastic Agents; Camptothecin; Carbazoles; Cell Line, Tumor; Drug Evaluation, Preclinical; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Glucosides; Humans; In Vitro Techniques; Indoles; Irinotecan; Mice; Microsomes, Liver; Topoisomerase I Inhibitors; Transplantation, Heterologous | 2005 |
Anthocyanins suppress the cleavable complex formation by irinotecan and diminish its DNA-strand-breaking activity in the colon of Wistar rats.
Topics: Animals; Anthocyanins; Camptothecin; Colon; DNA Breaks; DNA Damage; DNA Topoisomerases, Type I; Fruit; Glucosides; Irinotecan; Male; Plant Extracts; Rats; Rats, Wistar | 2013 |